Cargando…
Parthenolide targets NF-κB (P50) to inhibit HIF-1α-mediated metabolic reprogramming of HCC
We focus on investigating the role of Parthenolide (Par), a small sesquiterpenoid molecule, in hepatocellular carcinoma (HCC) and its effective target. Highly-metastatic HCC cells, MHCC97-H, were divided into the DMSO and the Par groups, of which the Par group was intervened at 5 and 10 mg/L doses....
Autores principales: | Liu, Xiaorong, Gao, Zhaofeng, Wang, Xiaoguang, Shen, Yiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648796/ https://www.ncbi.nlm.nih.gov/pubmed/36260873 http://dx.doi.org/10.18632/aging.204339 |
Ejemplares similares
-
Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
por: Dawood, Mona, et al.
Publicado: (2019) -
Involvement of Akt/NF-κB pathway in antitumor effects of parthenolide on glioblastoma cells in vitro and in vivo
por: Nakabayashi, Hiromichi, et al.
Publicado: (2012) -
Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway
por: Li, Xiao-he, et al.
Publicado: (2018) -
Parthenolide and costunolide reduce microtentacles and tumor cell attachment by selectively targeting detyrosinated tubulin independent from NF-κB inhibition
por: Whipple, Rebecca A, et al.
Publicado: (2013) -
Parthenolide attenuates LPS-induced activation of NF-κB in a time-dependent manner in rat myocardium()
por: Xie, Hong, et al.
Publicado: (2012)